Literature DB >> 17556594

Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.

Kurt Reifenberg1, Hans-Anton Lehr, Michael Torzewski, Gisela Steige, Elena Wiese, Ines Küpper, Christoph Becker, Sibylle Ott, Petra Nusser, Ken-Ichi Yamamura, Gerd Rechtsteiner, Tobias Warger, Andrea Pautz, Hartmut Kleinert, Albrecht Schmidt, Burkert Pieske, Philip Wenzel, Thomas Münzel, Jürgen Löhler.   

Abstract

Chronic heart failure is associated with an activation of the immune system characterized among other factors by the cardiac synthesis and serum expression of proinflammatory cytokines. There is unequivocal clinical and experimental evidence that the cytokine tumor necrosis factor-alpha is involved in the development of chronic heart failure, but a putative cardiotoxic potential of the proinflammatory cytokine interferon (IFN)-gamma remains primarily unknown. To investigate this issue we analyzed the cardiac phenotype of SAP-IFN-gamma transgenic mice, which constitutively express IFN-gamma in their livers and hence exhibit high circulating serum levels of this cytokine. SAP-IFN-gamma mice spontaneously developed chronic active myocarditis, characterized by the infiltration of not only CD4(+) and CD8(+) T cells but also Mac2(+) (galectin 3(+)) macrophages and CD11c(+) dendritic cells, eventually culminating in cardiomyopathy. Echocardiographic analyses exhibited a left ventricular dilation and impaired systolic function induced by IFN-gamma overexpression. IFN-gamma-mediated cardiotoxicity was associated with high-level cardiac transcription of the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-12 and the macrophage-attracting chemokines MCP1 and MIP1-alpha. Myotoxic IFN-gamma effects could not be detected in smooth or striated muscle tissue, suggesting cardiomyocellular specificity of the toxic IFN-gamma effect. The precise mechanism of IFN-gamma cardiotoxicity remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556594      PMCID: PMC1934522          DOI: 10.2353/ajpath.2007.060906

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Myocardial proteases and matrix remodeling in inflammatory heart disease.

Authors:  Susanne Rutschow; Jun Li; Heinz-Peter Schultheiss; Matthias Pauschinger
Journal:  Cardiovasc Res       Date:  2006-01-18       Impact factor: 10.787

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis.

Authors:  S C Smith; P M Allen
Journal:  Circ Res       Date:  1992-04       Impact factor: 17.367

7.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

9.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.

Authors:  Yoshihiro Higuchi; Charles F McTiernan; Carole B Frye; Brian S McGowan; Tung O Chan; Arthur M Feldman
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

View more
  38 in total

1.  Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Authors:  Anthony G Garcia; Richard M Wilson; Joline Heo; Namita R Murthy; Simoni Baid; Noriyuki Ouchi; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

2.  Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis.

Authors:  Pippa F Cosper; Pamela A Harvey; Leslie A Leinwand
Journal:  Am J Pathol       Date:  2012-10-08       Impact factor: 4.307

3.  Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Janusz Szkodzinski; Bartosz Hudzik; Marcin Osuch; Wojciech Romanowski; Bozena Szygula-Jurkiewicz; Lech Polonski; Barbara Zubelewicz-Szkodzinska
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

4.  Interferon regulatory factors in heart: stress response beyond inflammation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190

5.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.

Authors:  Da-Jun Hu; Jing Xu; Wei Du; Jian-Xin Zhang; Min Zhong; Ya-Nan Zhou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-26       Impact factor: 2.357

Review 8.  Galectin-3 in cardiac remodeling and heart failure.

Authors:  Rudolf A de Boer; Lili Yu; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2010-03

9.  Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis.

Authors:  Gabriel K Griffin; Andrew H Lichtman
Journal:  Circulation       Date:  2013-05-13       Impact factor: 29.690

10.  Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Authors:  Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.